跳至主要内容
临床试验/NCT01731613
NCT01731613已完成不适用

Adjustable Fortification of Human Milk Fed to Chinese Preterm Infants

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2012年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
1
主要终点
Time to reach 100kcal/kg/d of enteral nutrition

研究概览

简要总结

This clinical trial will compare how the individualized and fortified human milk feeding will help a premature infant grow.

详细描述

A total of 60 premature infants who will be randomized to receive either a standard fortification regimen (n=30) or an adjustable fortification regimen (n=30). The adjustable fortification regimen encompasses increasing / decreasing the amount of fortifier and adding supplemental protein guided by periodic determinations of the protein concentration in human milk (PCHM), body weight and blood urea nitrogen (BUN). Growth rate, tolerance of enteral feeding, days to achieve 100kcal/kg/d through enteral feeding, length of parenteral nutrition and NICU stays will be measured and compared between groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
10 Days 至 40 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Less than 34 weeks gestational age at birth
  • Birth weight within 800-1800 grams
  • Exclusively or mostly breastfed (greater than 80% if the feeding volume)
  • Tolerated enteral feedings of 60 ml/kg/d
  • Remain in the Neonatal Intensive Care Unit at least 14 days prior to hospital discharge,remain in the Neonatal Intensive Care Unit at least 10 days after enrollment
  • Signed Informed Consent

排除标准

  • Small for gestational age
  • Infants currently receiving ventilation therapy
  • Major congenital malformations
  • Suspected or documented systemic or congenital infections
  • Evidence of cardiac, respiratory, endocrinologic, hematologic, gastrointestinal, or other systemic diseases that may impact growth
  • Severe intraventricular hemorrhage (greater than grade II) or periventricular leukomalacia
  • Suspected or documented maternal substance abuse
  • Infants currently receiving glucocorticoids or infants who have received glucocorticoids within the past 28 days

研究组 & 干预措施

Standard Fortification

Active Comparator

receive human milk fortified with human milk fortifier(HMF) in the standard amount (4 packs /100 ml of HM) throughout the study

干预措施: human milk fortifier (Dietary Supplement)

Adjustable fortification

Experimental

encompasses increasing/decreasing the amount of human milk fortifier(HMF) and adding supplemental protein guided by periodic determinations of the protein concentration of human milk (PCHM), body weight, blood urea nitrogen(BUN)

干预措施: human milk fortifier (Dietary Supplement)

结局指标

主要结局

Time to reach 100kcal/kg/d of enteral nutrition

时间窗: participants will be followed until discharge, an expected average of 2 weeks

Days to reach 100kcal/kg/d of enteral nutrition

The weight gain velocity during hospitalization

时间窗: participants will be followed until discharge, an expected average of 2 weeks

The weight gain velocity(g/kg/d)

次要结局

  • metabolic indicators after enrollment, including BUN,prealbumin, albumin(participants will be followed until discharge, an expected average of 2 weeks)
  • The protein and energy ratio of enteral nutrition each week after enrollment(participants will be followed until discharge, an expected average of 2 weeks)
  • Time to reach 2000g of body weight(participants will be followed until discharge, an expected average of 2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Danhua Wang

Professor

Peking Union Medical College Hospital

研究点 (1)

Loading locations...

相似试验

Adjustable Fortification of Human Milk Fed to... | 临床试验